摘要
背景:额颞叶痴呆(FTD)是一种神经退行性疾病,其不对称地影响额颞叶,其特征在于行为异常,语言障碍和执行功能缺陷。遗传学研究确定了导致该疾病的突变,即微管相关蛋白Tau(MAPT),Granulin(GRN)和9号染色体开放阅读框72(C9orf72)突变,这有助于阐明Tau或TAR DNA沉积的分子途径结合蛋白43(TDP43)包涵体。然而,在大多数散发性FTD患者中,引发Tau或TDP43蛋白沉积的机制仍未被发现。 目标:我们旨在对FTD中免疫稳态的文献数据进行广泛的评估,以便为仍然是孤儿的任何治疗的疾病提供可能的基于证据的方法。 方法:追踪同行评审文献的书目数据库结构搜索,重点关注脑和FTD的自身免疫。 结果:本文共收录114篇论文。大部分研究(32)均以广泛的文献修订为代表,包括免疫,中枢神经系统(CNS)和自身免疫;对自身免疫性疾病的神经影像学检查(11)进行评估,并修改免疫调节方法(25)。发现6篇与FTD和自身免疫假说特别相关的论文,其他论文提及FTD的当前状态。 结论:总体而言,本综述有助于扩展FTD中可能的免疫假说的知识,提示自身免疫相关性神经退行性疾病的治疗前景,以减少或逆转该疾病。
关键词: 额颞叶痴呆,自身免疫,神经影像学,AMPA,治疗,染色体,tau。
Current Alzheimer Research
Title:Autoimmunity and Frontotemporal Dementia
Volume: 15 Issue: 7
关键词: 额颞叶痴呆,自身免疫,神经影像学,AMPA,治疗,染色体,tau。
摘要: Background: Frontotemporal Dementia (FTD) is a neurodegenerative disorder which asymmetrically affects the frontotemporal lobe, characterized by behavioural abnormalities, language impairment, and deficits of executive functions. Genetic studies identified mutations causing the disease, namely Microtubule Associated Protein Tau (MAPT), Granulin (GRN) and chromosome 9 open reading frame 72 (C9orf72) mutations, which contributed to elucidate the molecular pathways involved in brain depositions of either Tau or TAR DNA-binding protein 43 (TDP43) inclusions. However, in the majority of sporadic FTD patients, the mechanisms triggering Tau or TDP43 protein deposition are still to be uncovered.
Objective: We aimed to present an extensive evaluation of literature data on immune homeostasis in FTD, in order to provide potentially evidence-based approaches for a disease still orphan of any treatment.
Methods: A structured search of bibliographic databases from peer-reviewed literature was pursued focusing on autoimmunity in the brain and FTD.
Results: One-hundred-fourteen papers were included in this review. The majority of studies (32) were represented by extensive literature revision on immunity, central nervous system (CNS) and autoimmunity; neuroimaging papers (11) in autoimmune diseases were evaluated, and immunomodulatory approaches (25) were revised. Six papers were found specifically related to FTD and autoimmune hypothesis, the other papers referring to current state of art on FTD.
Conclusion: Overall this review contribute to expand the knowledge of a possible immune hypothesis in FTD, suggesting therapeutic perspectives in autoimmune related neurodegeneration, to reduce or revert the disease.
Export Options
About this article
Cite this article as:
Autoimmunity and Frontotemporal Dementia, Current Alzheimer Research 2018; 15 (7) . https://dx.doi.org/10.2174/1567205015666180119104825
DOI https://dx.doi.org/10.2174/1567205015666180119104825 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Tau Phosphorylation and Aggregation as a Therapeutic Target in Tauopathies
CNS & Neurological Disorders - Drug Targets Editorial: Current Vision of Systemic Autoimmune Diseases - From Diagnosis to Management
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of Bacteria and Viruses in Chronic Obstructive Pulmonary Disease
Current Respiratory Medicine Reviews The Anti-Inflammatory Role of Minocycline in Alzheimer´s Disease
Current Alzheimer Research Ferric Cycle Activity and Alzheimer Disease
Current Neurovascular Research Low Grade Inflammation as a Common Pathogenetic Denominator in Age-Related Diseases: Novel Drug Targets for Anti-Ageing Strategies and Successful Ageing Achievement
Current Pharmaceutical Design Central Selective Acetylcholinesterase Inhibitor with Neurotrophic Activity Structure-Activity Relationships of TAK-147 and Related Compounds
Current Medicinal Chemistry Cannabinoids for the Treatment of Schizophrenia: An Overview
Current Topics in Medicinal Chemistry Histone Post-translational Modifications to Target Memory-related Diseases
Current Pharmaceutical Design Advances in Neuroimaging for HIV-1 Associated Neurological Dysfunction: Clues to the Diagnosis, Pathogenesis and Therapeutic Monitoring
Current HIV Research Editorial Review 2015
Current Radiopharmaceuticals Melatonin Effects in REM Sleep Behavior Disorder Associated with Obstructive Sleep Apnea Syndrome: A Case Series
Current Alzheimer Research Impaired DNA Damage Repair as a Common Feature of Neurodegenerative Diseases and Psychiatric Disorders
Current Molecular Medicine Editorial: Advances in the Treatment of Neurodegenerative Diseases and Epilepsy
Current Pharmaceutical Design The Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP): A New Rodent Model to Test Palliative and Neuroprotective Agents for Parkinsons disease
Current Pharmaceutical Design Chondromodulin-I and Tenomodulin: The Negative Control of Angiogenesis in Connective Tissue
Current Pharmaceutical Design Association of Folate Level in Blood with the Risk of Schizophrenia
Combinatorial Chemistry & High Throughput Screening Telomerase Therapeutics for Degenerative Diseases
Current Molecular Medicine Niacin: From Mechanisms of Action to Therapeutic Uses
Mini-Reviews in Medicinal Chemistry Possible Roles of Microglial Cells for Neurotoxicity in Clinical Neurodegenerative Diseases and Experimental Animal Models
Inflammation & Allergy - Drug Targets (Discontinued)